Publication | Closed Access

A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model

Artemisinin TreatmentBreast OncologyMedicinePharmacologyImmunologyRegulatory T CellsImmune Checkpoint InhibitorBreast CancerMetronomic ChemotherapyCancer TreatmentImmunotherapyOncologyTumor MicroenvironmentLow-dose Cyclophosphamide Treatment